Insurance coverage varies significantly by plan and employer
Overweight and obesity over the adult life course and incident mobility limitation in older adults: the Health, Aging and Body Composition Study
The development of GLP-1 medications has provided a medical intervention that addresses the complex biological factors contributing to obesity
The mechanism involves activation of the glucagon-like peptide-1 (GLP-1)/GLP-1 receptor axis within the islets, stimulating premature functional maturation of -cells through the Akt-mTORC1-pS6 pathway, thereby disrupting normal islet developmental timing
Nothing here recommends, endorses, or instructs human use of DSIP, and the doses described are reported solely as a record of what was administered in published research settings
Structural and functional brain changes in acute Takotsubo syndrome